Daniela Pende

22.7k total citations · 4 hit papers
179 papers, 17.3k citations indexed

About

Daniela Pende is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Daniela Pende has authored 179 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Immunology, 47 papers in Hematology and 40 papers in Oncology. Recurrent topics in Daniela Pende's work include Immune Cell Function and Interaction (159 papers), T-cell and B-cell Immunology (119 papers) and CAR-T cell therapy research (33 papers). Daniela Pende is often cited by papers focused on Immune Cell Function and Interaction (159 papers), T-cell and B-cell Immunology (119 papers) and CAR-T cell therapy research (33 papers). Daniela Pende collaborates with scholars based in Italy, United States and United Kingdom. Daniela Pende's co-authors include Lorenzo Moretta, Alessandro Moretta, Cristina Bottino, Massimo Vitale, Maria Cristina Mingari, Roberto Biassoni, Claudia Cantoni, Simona Sivori, Stefania Marcenaro and Michela Falco and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Daniela Pende

177 papers receiving 17.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis

2001 1.4k citations Alessandro Moretta, Cristina Bottino et al. profile →
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS

1996 749 citations Alessandro Moretta, Cristina Bottino et al. profile →
Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

2003 705 citations Cristina Bottino, Daniela Pende et al. profile →
Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

1999 611 citations Daniela Pende, Simona Sivori et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Daniela Pende	15.7k	4.6k	3.6k	1.3k	1.2k	179	17.3k
Cristina Bottino	19.1k 1.2×	5.3k 1.2×	2.1k 0.6×	1.7k 1.4×	1.3k 1.1×	186	20.9k
Todd A. Fehniger	11.6k 0.7×	4.2k 0.9×	2.0k 0.6×	1.6k 1.3×	1.3k 1.1×	189	14.1k
Roberto Biassoni	13.2k 0.8×	3.1k 0.7×	1.5k 0.4×	1.3k 1.0×	992 0.8×	168	14.4k
Joseph H. Phillips	22.6k 1.4×	4.9k 1.1×	2.1k 0.6×	3.0k 2.4×	2.1k 1.8×	145	26.1k
Derek N.J. Hart	10.2k 0.7×	2.6k 0.6×	1.3k 0.4×	2.7k 2.1×	1.1k 0.9×	237	13.0k
Massimo Vitale	13.4k 0.9×	4.1k 0.9×	1.4k 0.4×	1.5k 1.2×	916 0.8×	108	14.8k
Yenan T. Bryceson	7.6k 0.5×	2.2k 0.5×	1.6k 0.4×	1.1k 0.9×	852 0.7×	138	9.1k
Eugene Maraskovsky	11.7k 0.7×	3.9k 0.8×	1.6k 0.5×	5.0k 3.9×	1.0k 0.9×	127	16.4k
Klas Kärre	12.9k 0.8×	3.3k 0.7×	1.1k 0.3×	1.8k 1.4×	1.4k 1.2×	180	14.7k
Andrea Velardi	10.3k 0.7×	4.1k 0.9×	7.7k 2.1×	1.2k 0.9×	1.5k 1.3×	201	14.5k

Countries citing papers authored by Daniela Pende

Since Specialization

Citations

This map shows the geographic impact of Daniela Pende's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Pende with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Pende more than expected).

Fields of papers citing papers by Daniela Pende

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Pende. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Pende. The network helps show where Daniela Pende may publish in the future.

Co-authorship network of co-authors of Daniela Pende

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Pende. A scholar is included among the top collaborators of Daniela Pende based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Pende. Daniela Pende is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cantoni, Claudia, Michela Falco, Massimo Vitale, et al.. (2024). Human NK cells and cancer. OncoImmunology. 13(1). 2378520–2378520. 13 indexed citations

Meazza, Raffaella, Loredana Ruggeri, Fabio Guolo, et al.. (2023). Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire. Frontiers in Immunology. 14. 1111419–1111419. 7 indexed citations

Falco, Michela, Raffaella Meazza, Claudia Alicata, et al.. (2022). Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes. HLA. 100(2). 107–118. 3 indexed citations

Meazza, Raffaella, Michela Falco, Paolo Canevali, et al.. (2022). Characterization of KIR⁺NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA‐C. HLA. 100(2). 119–132. 6 indexed citations

Merli, Pietro, Daria Pagliara, Federica Galaverna, et al.. (2021). TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders. Blood Advances. 6(1). 281–292. 25 indexed citations

Quatrini, Linda, Mariella Della Chiesa, Simona Sivori, et al.. (2021). Human NK cells, their receptors and function. European Journal of Immunology. 51(7). 1566–1579. 111 indexed citations

Acker, Heleen H. Van, Zoë P. Van Acker, Peter Ponsaerts, et al.. (2019). CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15. Cancers. 11(7). 1029–1029. 8 indexed citations

Falco, Michela, Simona Sivori, Raffaella Meazza, & Daniela Pende. (2019). Report from the Eleventh Killer Immunoglobulin‐like Receptor (KIR) Workshop: Novel insights on KIR polymorphism, ligand recognition, expression and function. HLA. 94(2). 100–110. 2 indexed citations

Sivori, Simona, Raffaella Meazza, Concetta Quintarelli, et al.. (2019). NK Cell-Based Immunotherapy for Hematological Malignancies. Journal of Clinical Medicine. 8(10). 1702–1702. 50 indexed citations

10.

Walwyn-Brown, Katherine, Karolin Guldevall, Mezida B. Saeed, et al.. (2018). Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. The Journal of Immunology. 201(7). 2028–2041. 18 indexed citations

11.

Pende, Daniela, Raffaella Meazza, Stefania Marcenaro, Maurizio Aricò, & Cristina Bottino. (2018). 2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infection. Clinical Immunology. 204. 31–36. 15 indexed citations

12.

Bono, Marı́a Rosa, Daniela Pende, Alice Bertaina, et al.. (2018). Analysis of KIR3DP1 Polymorphism Provides Relevant Information on Centromeric KIR Gene Content. The Journal of Immunology. 201(5). 1460–1467. 5 indexed citations

13.

Huse, Kanutte, Arne Kolstad, Klaus Beiske, et al.. (2017). T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling. Clinical Cancer Research. 24(4). 870–881. 76 indexed citations

14.

Meazza, Raffaella, Michela Falco, Stefania Marcenaro, et al.. (2017). Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients. European Journal of Immunology. 47(6). 1051–1061. 16 indexed citations

15.

Villa, Giuseppe, Enrico Ferrari, Silvia Morbelli, et al.. (2017). Prevention of systemic toxicity in hyperthermic isolated lung perfusion using radioisotopic leakage monitoring. International Journal of Hyperthermia. 34(4). 469–478. 1 indexed citations

16.

Cifaldi, Loredana, Paolo Romania, Michela Falco, et al.. (2015). ERAP1 Regulates Natural Killer Cell Function by Controlling the Engagement of Inhibitory Receptors. Cancer Research. 75(5). 824–834. 53 indexed citations

17.

Cifaldi, Loredana, Elisa Lo Monaco, Matteo Forloni, et al.. (2011). Natural Killer Cells Efficiently Reject Lymphoma Silenced for the Endoplasmic Reticulum Aminopeptidase Associated with Antigen Processing. Cancer Research. 71(5). 1597–1606. 64 indexed citations

18.

Ruggeri, Loredana, Antonella Mancusi, Marusca Capanni, et al.. (2007). Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.. Blood. 110(1). 433–440. 456 indexed citations

19.

Maccalli, Cristina, Daisuke Nonaka, Adriano Piris, et al.. (2007). NKG2D-Mediated Antitumor Activity by Tumor-Infiltrating Lymphocytes and Antigen-Specific T-Cell Clones Isolated from Melanoma Patients. Clinical Cancer Research. 13(24). 7459–7468. 24 indexed citations

20.

Nedvetzki, Shlomo, Stefanie Sowinski, Robert A. Eagle, et al.. (2007). Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood. 109(9). 3776–3785. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact